Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;13(2):95-96.
doi: 10.1111/cen3.12692. Epub 2022 Feb 28.

Nerve conduction studies support the classification of SARS-CoV-2 associated Guillain-Barre subtypes

Affiliations

Nerve conduction studies support the classification of SARS-CoV-2 associated Guillain-Barre subtypes

Josef Finsterer et al. Clin Exp Neuroimmunol. 2022 May.
No abstract available

Keywords: COVID‐19; SARS‐CoV‐2; neuropathy; polyradiculitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. da Silva GF, da Silva CF, Oliveira R, Romancini F, Mendes RM, Locks A, et al. Guillain‐Barré syndrome after coronavirus disease 2019 vaccine: a temporal association. Clin Exp Neuroimmunol. 2021. 10.1111/cen3.12678 - DOI - PMC - PubMed
    1. Yuan J, Zhang J, Zhang B, Hu W. The clinical features of patients concurrent with Guillain‐Barre syndrome and myasthenia gravis. Neurosciences (Riyadh). 2018;23(1):66–70. 10.17712/nsj.2018.1.20170209 - DOI - PMC - PubMed
    1. Gigli GL, Vogrig A, Nilo A, Fabris M, Biasotto A, Curcio F, et al. HLA and immunological features of SARS‐CoV‐2‐induced Guillain‐Barré syndrome. Neurol Sci. 2020;41(12):3391–4. 10.1007/s10072-020-04787-7 - DOI - PMC - PubMed
    1. Finsterer J. Neurological side effects of SARS‐CoV‐2 vaccinations. Acta Neurol Scand. 2022;145(1):5–9. 10.1111/ane.13550 - DOI - PMC - PubMed